Introduction
A large number of platinum coordination complexes have been synthesized and tested for their anti-tumor activity (Hacker et al., 1986; Sadler et al., 1984) . Of these, cisplatin [czr-dichlo~odiammieplatinum (II) :CDDP] has proven active against a number of animal (Leh and Wolf, 1976; Rosenberg and VanCamp, 1970) and human tumors (Durant, 1980) , and has been approved for clinical use in treating testicular (Williams and Einhorn, 1980) and ovarian tumors Holland et al., 1980) . A hindrance to the wider use of potent inorganic chemicals in medicine is the general ignorance of their mechanisms of action as therapeutic agents and in inducing severe toxicities (Powis and Hacker, 1991; Schurig et al., 1980) . The primary mechanism for the inhibition of tumor growth by cisplatin has been suggested to be through the inhibition of DNA synthesis. Denaturation of DNA through intrastrand or interstrand cross-links may be the initial step in the arrest of tumors. However, if DNA synthesis has already been completed, cell replication can still be prevented by inhibition of cytokinesis (Kopf-Maier and Muhlhausen, 1992; Aggarwal, 1974) , suggesting a possible interaction with proteins. The mechanism of this Correspondence to: Dept. ofZoology, Michigan State Univ., East Lansing, MI 488241115, interaction is still not clearly understood. An attempt has been made to demonstrate such an interaction of some heavy metal coordination complexes with some of the enzymes (Aull et al., 1979 (Aull et al., ,1980 . Changes in the enzyme concentrations have been shown to precede morphological changes and can serve as reliable indicators of cellular changes andlor as an index for the functional state of the cell (Wachsmuth, 1981a,b) . Indeed, alkaline phosphatase and aminopeptidase have provided an easy way to quantify injuries in nephrotoxicity studies using renal tissue sections, homogenates, and urine (Wachsmuth, 1981b) . Similarly, glucose-6-phosphatase, alkaline phosphatase, and succinic dehydrogenase have been used as valuable indicators of toxic side effects in the liver (Feuer et al., 1965) . Plasma membrane enzymes have been considered as potential markers in chemical carcinogenic studies (Ingleton et al., 1979) . Urinary enzyme excretion has often been used as a model for screening functional and/or lesional damage to the kidney in disease (Dubach, 1979; Plummer et al., 1979) , when new drugs are introduced (Beck et al., 1977; Chohan et al., 1977) , or due to the use of a variety of nephrotoxic agents (Nomiyama et al., 1974; Wright and Plummet, 1974) . Early nephrotoxicity, although not detectable with conventional clinical renal function tests (Plager, 1976) , may be indicated by the increased activities of urinary enzymes as a result of decreased resorption of filtered serum enzymes or discharge of enzymes due to tubule damage (Adelman et al., 1979) .
Urinary enzyme assay has been shown to be a sensitive indica-tor of damage caused by cisplatin (Pierce et al., 1979) . However, glucose and albumin tend to demonstrate injury to the tubule reabsorption capacity long before cell injury is sufficient to cause lysosomal enzyme release (Aggarwal et al., 1980a; Pierce et al., 1979) . Because the role of calcium ions, Ca2+-adenosine triphosphatase (ATPase), Na+,K+-ATPase, 5'-nucleotidase, and alkaline phosphatase in phosphate estet and inorganic phosphate metabolism and transfer of various ions and metabolites across the plasma membrane, the effects of cisplatin has been studied histochemically on tumor cells in both the presence and the absence of the immune system (Aggatwal and Niroomand-Rad, 1983) .
The present study is an effort to correlate the enzymatic changes in the various tissues (using sections or homogenates) affected by cisplatin and its various analogues with the excretion of enzymes in the urine, to better understand the mechanisms of various toxicities. If the mechanisms of action of these new drugs are understood, ways can be found to combat the toxicities they produce.
Materials and Methods

Compounds Tested for Tomcity
The various platinum coordination complexes used in this study were supplied by Johnson Matthey Research Laboratories (Reading, UK) and the Drug Synthesis and Chemistry branch of the National Cancer Institute (Bethesda, MD). Solutions were prepared fresh before use and were protected from light. All compounds were administered as a single IP injection at the concentrations specified. (NSC 250427) . This compound was prepared as a stock solution of 12 mgllo ml in 0.3 M glucose with 100 mM NaHC03 and was administered as 1 m1/100 g body weight.
. czs-Dichloro-trans-dihydroxobis (isopropylamine) platinum (IV):
[(C3H7NH2)2Pt(OH)2CI2]: CHIP. This compound was used at a concentration of 40 mglkg body weight. It was prepared as a stock solution of 40 mgllO ml on 0.3 M glucose with 1% NaHCO3.
Carboplatin: 1,l-cyclobutanedicarboxylatodiammineplatinum (11):
[Pt(CgH&) (NH3)2]: CBDCA: (NSC 241240). The compound was used at a concentration of 50 mglkg body weight. The stock solution was prepared fresh as 50 mgllO ml in 5% dextrose. 7. Dichloro-1,2-diamminocyclohexaneplatinum (11): ci~[C6H14N2) (PtCIz)]: DACH-C12. This compound was used as 20 mglkg in 0.15 M saline solution. 8. Platinum thymine blue: [Pt(NH3)2(CrHrN202)2]. Platinum thymine blue was prepared by reacting [(NH3)2 Pt(H20)2IH and pyrimidine (thymine) at 37'C for 190 hr and was used at 300 pmollkg (100 mglkg), a dose about 10 times the effective dose of CDDP ( A g p a l et al., 1980a).
A group of CDDP-treated animals were also given daily injections (IV) of calcium (1.1 ml of 1.3% CaCl2) at 0800 on the day of CDDP treatment and each day thereafter up to the day of euthanasia.
Animals
All experiments were conducted on male Wistar rats (weight 180-250 g) bred in our own laboratory from an original stock [Ctl: (WI) BR] supplied by Charles River Breeding Laboratory (Wilmington, MA). The present results are based on an average of 500 animals over a period of 5 years. Treated and control animals were sacrificed at 24-hr intervals (10-20 in each group at any given time) over a period of 5 days. Some animals were kept under observation for as long as 30 days and 2, 6, and 10 months after the drug injection. Animals were killed by decapitation after mild anesthesia, in compliance with the Guide for Care and Use of Laboratory Animals.
Collection of Serum
Blood was collected daily after drug injections by orbital sinus puncture under light ether anesthesia. Between 10 and 12 blood samples were collected in each treatment and control group at each sampling period. All blood samples were collected between 1000 and 1100 hr. Blood was allowed to clot overnight at 4 T and the serum was separated by centrifugation for enzyme activity. Complete blood Ca2' and Pi analysis was conducted with atomic absorption spectroscopy.
Collection of Rat Urine
Urine collections were made by placing each animal individually in metabolic cages with free access to water but no food between the hours of 0800 and 1700. Urine was collected in test tubes over ice and kept frozen until use. The pH of each sample was recorded before any further analysis. Urine was concentrated by centrifugation at 3000 x g for 10 min and dialysis for 4 hr against ice-cold distilled water. Further concentration was accomplished by procedures outlined by Lathwood et al. (1972) .
Tissues
Small pieces of kidney and liver were excised from the animals. Tissues were sliced into two pieces, Half the tissue pieces were put on a metal stub smeared with OCT compound (Lab-Tek) (Miles Laboratories; Naperville, IL) and frozen for sectioning on a cryostat microtome, while the other half of the tissues was fixed in 1% glutaraldehyde and 1% formaldehyde in 0.1 M cacodylate buffer (pH 7.2) for 1 hr or in alcoholic Bouin's (Humason, 1979) for 1 hr. After fixation the tissues were rinsed in sucrose buffer and stored at 4'C (0.1 M cacodylate + 7% sucrose). Frozen sections (6-10 pm thick) of the fresh frozen or fixed tissues were cut for further incubation in various media for enzyme studies.
Cytochemical Studies
Glycogen. Sections (7-10 pm) of alcoholic Bouin's-fixed tissues were used to perform the periodic acid-Schiff technique (Humason, 1979) for the general distribution of carbohydrates. Adjacent sections were used for digestion with salivary amylase to serve as controls for glycogen.
Phosphatases. Frozen sections (6 pm) picked up on standard glass coverslips were immersed in buffered (cacodylate buffer 0.1 M, pH 7.2) 1.5% paraformaldehyde and 1% glutaraldehyde containing 7 % sucrose for 3-5 min at 4'C. Such sections were washed three times in the same buffer before immersion in the proper incubation medium. Small pieces of tissue Ca"(25 NAC (2.5mM) / Succinate (5mM) Figure 1 . Ca2' electrode trace showing the effects of CDDP and diol on Ca2' transport by the livedkidney mitochondria. Diol caused an efflux of Ca2' from the mitochondria. NAC was able to antagonize the effects of diol, causing Ca2' reuptake by the mitochondria. CDDP or diol administered along with NAC had no effect on the Ca2' within the mitochondria. glucose-6-phosphate as the substrate. Parallel incubations were run with P-glycerophosphate as the substrate at the same p H (6.2) to differentiate between G-6-Pase and AP or AcP.
-
Y-Nucleotidase.
For visualization of 5'-nucleotidase (5'-N) activity, sections and tissue blocks were incubated at 37'C for 60 min according to the technique of Uusitalo and Karnovsky (1977) with 0.1 M Tris-maleate blocks were processed at the same time in the various incubation media for electron microscopic studies.
A/Ra/ine Phosphatase. Alkaline phosphatase (AP) activity was detected after incubation of tissue sections and tissue blocks at 37'C for 60 min in a medium outlined by Hugon and Borgers (1966) . The adjacent sections were incubated in medium that also contained 0.5 m M levamisole hydrochloride or 50 m M L-phenylalanine (Borgers, 1973) as inhibitors of AP, to serve as controls.
Acid Phosphutase. Methods designed by Gomori (1952) and Essner (1973) with !3-glycerophosphate as the substrate were used for acid phosphatase (AcP). The incubation was carried out for 60 min at 37°C with 0.1 M Tris-maleate buffer ( p H 5.2). In the control incubations the substrate was omitted.
Glucose~6-phosp~atuse.
For visualization of glucose-6-phosphatase (G-6-Pase), sections and tissue blocks were incubated at 37°C for 45 min according to the technique of Wachstein and Meisel (1956) . using sodium-D- buffer (pH 7.3). The control medium also contained 50 mM of P-methylene adenosine diphosphate (ADP) (Rodan et al., 1977) , or the substrate adenosine 5'-monophosphate (AMP) was omitted.
Cp-activated ATPaJe. Ca2'-ATPase was detected by incubation of tissue blocks or sections in an incubation medium according to the technique of Cutler et al. (1978) . The incubation lasted for 60 min at 37'C with a pH optimum of 7.3. The control incubation medium also contained 15 pg/ml quercetin (an inhibitor of Ca2'-ATPase) (Fewtrell and Comperts, 1977) , or the substrate ATP was omitted from the incubation medium. To eliminate any interference by alkaline phosphatase, sections were also pretreated with 0.5 mM levamisole for 1-3 hr (Borgers, 1973) . Na+,k"-activated ATPase. Na',K'-ATPase activity was determined by incubating tissue blocks or sections in a medium recommended by Mar- chest and Palade (1967) . with Tris-maleate buffer (pH 7.3) at 37'C for 60 min. Controls were incubated in medium without sodium chloride or ATP. All tissue samples from the various incubation media were washed three times in ice-cold corresponding buffer identical to the one used for incubation.
Sections were treated with I0h yellow ammonium sulfide in cacodylate-sucrose buffer to convert the lead phosphate to lead sulfide and were mounted in glycerin jelly after proper washing. Slides were viewed with a Zeiss photomicroscope I1 and micrographs of random areas were prepared. Small blocks of tissues that were incubated along with the sections were post-fixed in buffeted 1% os04 (pH 7.3) for 1 hr at 4'C and processed for routine electron microscopy.
Thiol Groups. Thiol groups (SH) were localized according to the method of Engel and Zerlotti (1963) involving treatment of tissue sections with 95% ethanol, followed by staining with the azomercurial reagent 4-u-dimethylaminobenzene azo) phenylmercuric acetate, with 95 % ethanol wash. Controls were prepared by pre-incubation in N-ethylmaleimide (75 mM) in phosphate buffer (pH 7.0) at 37'C for 2 hr (Barnett and Seligman, 1952) . blocking the thiol groups, or by controlled trypsin (protease) digestion, demonstrating the protein-bound nature of the thiol groups. The sections were mounted in Permount (Fisher Chemical; Fair Lawn, NJ) and observed under monochromatic blue (458 nm) light.
GZutaraLdehyde-Pyroantzmonate Fzutiue fir Ca2+ LocaLization
Kidney pieces from normal and drug-treated animals were excised and immediately transferred to the fixative containing 2% glutaraldehyde and 2 % potassium pyroantimonate (pH 8.5) (ICN Pharmaceuticals; Plainview, NY). Tissues were fixed in the above fixative for 4 hr and post-fiued in 1% Os04 at room temperature before being processed for electron microscopy (Weakley, 1979) . Control tissues were placed in a saturated solution of ethylene glycol bis [P-amino ethyl ether]-N,N'-tetraacetic acid (EGTA) for 4 hr before being processed for electron microscopy. Ultra-thin sections were also exposed to EGTA-for 1 hr at 60°C as an alternative.
Thin sections (300-800 A) of selected areas were examined in a Hitachi HU IIE electron microscope either unstained or counterstained with uranyl acetate and lead citrate. The enzyme reaction product was visualized as dark brown coloration by light microscopy or as electron-dense deposits by electron microscopy. Records were made of high response (+ + + + ), moderate response ( + + + ), low response (+ + ), or poor response (+ ), based on visual observations. These positive responses were based on quantitative measurements of the reaction product with a Unitron Imagerek System (Unitron; Plainview, NY) with a Newvicon camera fitted to a compound microscope. Random unit areas of control and experimental slides were used to make density measurements to give the exact mounts ofenzyme reaction product as a rdlection of enzyme activity in arbitrary units.
Mitochondrial Studies: Isolation, Calcium Transport, Oxygen Consumption, ATPase Activity
Because of the considerable knowledge gained in recent years in our understanding of Ca" transport across the inner mitochondrial membranes. it was considered appropriate to try the effects of cisplatin on isolated kidney mitochondria. Mitochondria were prepared from normal rat kidneys according to procedures already outlined by Reed and Bygrave (1974) . The final pellet was suspended in 250 mM sucrose, 2.5 mM Hepes (pH 7.4) at 4'C to give a protein concentration (estimated by biuret reaction) of about 50 mglml.
Oxygen consumption by mitochondria was measured polarographically with a membrane-covered electrode (Reed, 1972) . The Ca" concentration in the medium reflecting a transport across the mitochondrial membranes was continuously measured by an ion-sensitive Ca2' electrode (Radiometer; Copenhagen, Denmark) with a combination pH electrode as reference. The incubation medium contained 150 mM KCI, 3 mM Hepes (pH 7.4), and 2 pM rotenone. Mitochondria were added (2 mg protein). followed by cisplatin or its hydrolysis product diol. CaZ' (usually 12.5 pM) was added and transport was initiated about 1 min later by the addition of 5 pM succinate (Crompton et al., 1976) . The signal from the Ca2' electrode was converted to give an anti-logarithmic output on a Rikidenki recorder. Initial rates of CaZ' transport were obtained by drawing a tangent at time zero to the Ca2' electrode trace. Ca2* efflux by various diaquo species (Aggaml et al.. 1980b ) was used to study various agents such as N-acetyl-L-cysteine (600 pM) for a reversal effect on the mitochondria. This also served as a test for screening agents that serve to block the toxicity ofvarious platinum coordination complexes.
ATPase activity was monitored by following the release of inorganic phosphate. Samples were quenched with trichloroacetic acid ( K A ) and assayed by the micromethod of Baginski et al. (1967) and by a modified procedure as described by Dulley (1975) . The incubation medium consisted of 25 mM Tris buffer (pH 7.4). 20 pg mitochondrial protein. 0.025 mM MgC12, and 2.5 pM EGTA. To this total volume of 0.5 ml. cir-diamminediaquoplatinum (11) was added in concentrations of 10-40 pM.
Biochemical Assays
Detailed biochemical quantitations were carried out on alkaline and acid phosphatases only. Kidney cortex from normal or drugtreated rats were homogenized at 0-4°C in 5 ml of 0.1 M carbonate-bicarbonate buffer (pH 10.0) or 0.1 M acetate buffer (pH 5.2). using 16 full strokes of a Potter-Elvejhem homogenizer fitted with a teflon pestle rotating at 2000 rpm. The homogenate was centrifuged at 33.000 x g for 20 min. Supernatant was stored on ice until used. Alkaline and Acid Phosphatases. Supernatant (0.3 ml) of the kidney homogenate, urine, or serum protein was added to 0.6 ml of carbonate-bicarbonate buffer (pH 10) or 0.1 M acetate buffer (pH 5.2) and mixed with 0.03 ml of 100 mM magnesium sulfate. The mixture was incubated at 30°C in a water bath for 10 min before starting the reaction by adding 0.07 ml of 87.6 mM disodiump-nitrophenyl phosphate dissolved in 0.1 ml of the same buffer (Leathwood and Plummer, 1969) . Any increase in the absorption at 400 nm was recorded as a result of the release of inorganic phosphate (Pi) (Lojda et al., 1979) . using a Beckman 25 spectrophotometer with recorder. The cuvettes used had a 1-cm path length and a 1-ml capacity. The controls consisted of incubation medium without the enzyme sample or medium to which 0.5 mM levamisole had been added (Borgers, 1973) .
The extinction given by the controls was subtracted from the test samples. Enzyme activity was further calculated using Beers' law and was expressed as nanomoles nitrophenyllminlmg protein (Vorbrodt and Borun, 1979) . Protein determinatians were conducted according to methods described earlier (Aggarwal and Niroomand-Rad, 1983) .
Results
Effects of Cisplatin and c is-Diamninediaquoplatin um (I4 on Ca" Transport in Mitochondria
Succinate stimulation of mitochondrial respiration, initially inhibited by rotenone at State I, leads to an accumulation of Ca2+ by the mitochondria. Exposure to the diaquo-equated [ ciS-(NH3)z Pt(H20)2I2' form of cisplatin (diol) induced uncoupling of oxidative phosphorylation, causing spontaneous release of Ca2+ from the mitochondria (Figure 1) and producing swelling of the mitochondrial inner membranes observable by electron microscopy (Figure  2) . Cisplatin, however, did not have any effect on Ca2' release even at high concentrations (500 pM). Moreover, the release of CaL+ from mitochondria was mostly dose dependent (Figure 3) . This Caz+ efflux by diol was easily reversed by N-acetyl-Lcysteine (NAC) (2.5 mM) without any lag time. A complete reversal was observed even after diol had exerted its effect (Figure 1 ).
Stimulation of Respiration by Cisplatin and Diol
The energy requirement in the above respiration-linked Ca2+ transport was reflected by increased oxygen consumption, as measured by an oxygen electrode (Figure 4) . Again, the oxygen consumption was directly proportional to the concentration of diol used. However, NAC completely negated the effect of diol without any lag time. When diol and NAC were added simultaneously, there was no effect on oxygen consumption by the mitochondria (Figure 5 ). Cisplatin alone had no effect.
Effects of Cisplatin and Diol on m a s e Activity in the Mitochondria
Effects of cisplatin and diol on ATPase activity in the mitochondrial membranes, as measured by the amounts of Pi released in the presence of excess ATP, are shown in Figure 6 . Cisplatin, even at high concentrations (500 pM), had little or no effect, whereas diol led to an inactivation of ATPase activity that was related to its concentration in solution. ' Significantly different from normal rats @<O.Ol).
dUrine pH was variable, between 7.4-7.6.
Ca2+ and Pi in Blood Samples from Normal and Cisplatin-treated Rats
Cisplatin treatment induced lowered CaZ+ and Pi levels in the blood, which reached the lowest level by Day 5 of such treatment. These levels were again dose dependent (Figure 7) . The depressed levels of Ca2+ and Pi remained depressed for periods of up to 60 days. Platinum thymine blue, when used at a dosage of 100 mglkg, also reduced levels of both Ca2+ and Pi by Day 5.
Ultrastructural Localization of Ca2+ in Kidney Proximal Tubule Cells
In sections of kidney proximal tubule cells, electron microscopic observations showed Ca2+-containing antimonate granules mostly within the mitochondrial matrix, bound to the inner membranes (~1 . 2 granuleslmitochondrion), in the nucleus, at the basal laminae ( Figure 8 ), and at the apical brush border ( Figure 9A ) of the proximal tubule cells. Cisplatin treatment, however, induced drastic changes in the Ca2+ distributions as compared with the normal distribution. There was a significant decrease in the Ca2+ levels from the apical brush borders ( Figure 9B ) and the mitochondria after 3-5 days of treatment (z0.07 granuleslmitochondrion). At the same time there was a considerable increase in the granulation at the basal lamina and the basal infoldings ( Figure 10 ). The lysosomes showed maximum electron density and a heavy Ca2+ deposit at their membranes. By 7 days after cisplatin treatment there was a complete reversal of Ca2+ distribution back into the mitochondria ( Figure 11 ), but only a negligibly low number of Ca2+containing antimonate granules could be observed at the apical brush border. Thirty days after cisplatin treatment the CaZ+ distribution appeared to be normal both inside the mitochondria and on the plasma membrane.
Urine Enzyme Analysis
Urine analysis of acid phosphatase and alkaline phosphatase activity revealed significantly (~K0.01) higher levels than normal at 3 and 5 days after 7 mg/kg CDDP, with the maximal increase occurring at Day 3. At Day 7 the AP levels dropped far below normal (Figure 12 ), while the acid phosphatase levels were barely detectable after 7 days. The enzyme activity of both AP and AcP in the urine was found to be dose related (see Table 1 ).
Carbohydrates
Cisplatin induced a significant depletion of glycogen levels in the hepatocytes (Figure 13 ). This was again dose dependent, being most severe after 9 mg/kg treatment and after only 3 days, whereas lower dosages (3-5 mg/kg) had the same effect only after 5-7 days. In the kidney, however, cisplatin had a different effect on glycogen metabolism. It induced a considerable accumulation of glycogen within the cells of both the proximal and the distal tubules. The PAS-positive material from the luminal border of the tubule cells, however, was observed to be considerably reduced after cisplatin treatment ( Figures 14A, and 14B ). This was most striking after 9 mg/ kg treatment. In the kidney sections from these cisplatin-treated animals one could observe PAS-positive material in the lumen of the distal convoluted tubules, loop of Henle, and the collecting ducts ( Figure 15 ) within 3 days.
Alhdine Phosp hatase
AP activity, as depicted by the reaction product after 1 hr of incubation, appeared as dense deposits only on the bile canaliculi of the liver and the plasma membrane of the microvilli. In kidney sections, densitometric measurements of the reaction product demonstrated that in a random section of random areas the reaction product occupied about 23% of the total area viewed, whereas after cisplatin (5 mglkg) treatment for 5 days using identical sections and incubations, the reaction product occupied only 4.28% of the total viewing area ( Figures 14C and 14D ). Again, 9 mglkg treatment had the same effects, but only after 3 days. The above observations were further confirmed by electron microscopic studies ( Figure 16A ). which demonstrated that the enzyme was distributed uniformly on the microvilli in the proximal tubule cells from normal kidney. However, cells from the kidney of a drug-treated animal showed clumping of the enzyme and in places these clumps of enzymes, along with the microvillar plasma membrane, were in the process of being discarded into the lumen ( Figure I6B ). with the result that one could observe a decrease in the number of microvilli per unit area after cisplatin treatment. After 5 days one could observe large portions of the microvilli without any AP activity ( Figure 17 ). Such cells underwent lysis or showed recovery depending on the animal's state of hydration. After 2 months of cisplatin treatment (9 mglkg), complete recovery (Figure 18 ) of the enzyme levels on the microvilli was observed. The cells that were lysed persisted as cysts and were not replaced. even after 6 months (Figure 18 ). Cisplatin-treated and daily calcium-injected animals showed a more or less normal AP distribution on the brush borders of their proximal tubule cells.
Acid Phosphatase
Cisplatin treatment induced considerable increase in the number of lysosomes both in the liver and the kidney (Figures 14E-14H) . This was again a dose-dependent and time-dependent phenomenon. By electron microscopy one could observe, especially after high dosages (9 mglkg), that some of the lysosomes did open up, releasing their hydrolytic enzymes into the cytoplasm and causing cell damage or complete lysis of the cells.
SI-Nucleotidase
As in the case of AP, the cytochemical reaction for YN was localized mainly on the plasma membranes of the microvilli, capillaries, glomeruli, and the basal borders. The enzyme reaction product occupied about 20-25% of the total viewing area in the kidney cortex. Cisplatin treatment induced a decrease of the enzyme in the plasma membrane, whereby about 70-80% of the enzyme activity was probably lost by discarding of portions of the membrane into the lumen, as was the case for AP. In the liver the enzyme was mostly distributed along the biliary canaliculi. The sinusoid were particularly well outlined.
Nu+, K'-ATPase
Na+,K+-activated ATPase, probably involved in the active transport of sodium and potassium, was associated mainly with the basal and lateral cell membranes of the proximal and the distal convoluted tubule cells. Cisplatin treatment induced a considerable decrease in the enzyme activity in both the liver and kidney cells, depending on the dosage and the length of treatment (5 mg vs 7 mg; 3 days vs 5 days). There was complete recovery of the enzyme on the plasma membrane after 2 months of drug treatment. However, cells destroyed during the treatment never recovered. Ouabain-exposed sections demonstrated no enzyme reaction.
Cu2+-ATRuse
Frozen sections (7 pm) of kidney from normal animals, when incubated in the medium for Ca2'-ATPase activity, demonstrated the reaction product as dense granules, mostly on the basolateral borders ( Figure 19) , at both the light and the electron microscopic level. The sections from the cisplatin-treated animal kidneys did not show any reaction product after 3 days of treatment. Control sections that were exposed to quercetin before incubation for Ca2+-ATPase demonstration were negative. Cisplatin-treated animals demonstrated a normal distribution pattern of Ca2+-ATPase on their membranes 2 months post recovery. A false-positive reaction was observed at the brush border of the proximal kidney tubule cells for Ca2+-ATPase but the reaction was negative when the sections were pre-treated with levamisole, indicating an interference due to AP.
Glucose-G-phosphutuse
Unlike the AP and Ca2+-ATPase or Na+,K+-ATPase, G-6-Pase was localized mainly in the cytoplasm (endoplasmic reticulum and the microsomes) of the kidney tubule cells (Figure 20) and the liver parenchymal cells (Figure 21) . After 3 days of cisplatin treatment the amount of enzyme was significantly low. Effects of various analogues of cisplatin on the activity of various phosphatases in the kidney are depicted in Table 2 . Carboplatin (CBDCA) , showing the least effect on the membrane phosphatases, has further been compared with cisplatin with respect to specific membrane enzymes (see Table 3 ).
Eflect of Various Plutinum Coordination Complexes on Kidney Sections In Vitro
There was no detectable increase or decrease of any phosphatase activity (acid phosphatase, alkaline phosphatase, Ca*+-ATPase, Na',K*-ATPase, 5'-nucleotidase, or glucose-6-phosphatase) when fixed or unfixed frozen sections of normal kidney were incubated in CDDP (9 mgl1OO ml saline) or in any of the platinum coordination complexes, including diol, for up to 4 hr. The unfixed frozen sections did not maintain their structural integrity well in the incubation medium. However, the intensity of various reaction products on the microvilli or the basolateral plasma membrane was just as strong as in the control sections, suggesting no inactivation of the various enzymes at therapeutic dose levels. 
Effects of Cisplutin and Curboplutin on the SH Groups
Microdensitometric measurements of sections stained for -SH groups showed an insignificant level after 5 days of cisplatin treatment. Carboplatin treatment for 5 days induced a drop of only about 2 5 % as compared with the controls. This was significantly less when compared with sections from cisplatin-treated animals. It was difficult to pinpoint the distribution patterns of -SH groups because of the general cytosolic distribution at the light microscopic level. Detailed studies have already been reported and will not be repeated here (Batzer and Aggarwal, 1986 ).
Discussion
Cisplatin (CDDP) has been demonstrated to be toxic predominantly to the kidneys ), gastrointestinal tract (Aggarwal et al., '1980a , gonadal tissues (Drasga et al., 1983) , bone marrow, and ear (VonHoff et al., 1979) . with some involvement of the peripheral nervous system and the immune system (Aggarwal and Fadool, 1987) . Gastrointestinal and renal toxicities are the major 
dose-limiting factors in cisplatin treatment. Gastrointestinal fox-
the liver show that cisplatin by itsel has no effect on res€ ratory metabolism (Agganval et al.. 1980b) . Hawever, the hydroxy species does affect the State 3 respiration. inducing an efflux of the Ca2' and resulting in mitochondrial dysfunction due to the accumulation ofcalcium (Gemba et al., 1987; Aggarwal et al.. 1980b) . Mitochondria do function to buffer the cytosolic calcium concentrations (Bonventre and Cheung, 1986; Reed and Fariss, 1984) . It is the initial inhibition of the mitochondrial respiration, resulting icity (vomiting) can be controlled by various anti-emetic agentssuch as chlorpromazine. Various methods have been used for amclioration of kidney toxicity (Walker and Gale, 1981) . but hydration and diuresis have proven to be more effective through increased urinary excretion of platinum during the first f m hours ofdosing (Littent. 1984) . The mechanism of the toxicity is far from clear. In vitro studies using isolated mitochondria from rat kidney or , e in uncoupling of oxidative phosphorylation and eventual inhibition of ATP synthesis, that probably is the blow to the normal functioning of the energy-requiring cell processes (Gordon and Gattone, 1986) . Indeed, injection of small quantities of ATP-MgClz has been shown to protect normal kidney functions (Sumpio et al., 1985) . Intracellular calcium is important in the metabolism of cells and perturbation of its homeostasis may result in cytotoxicity (Orrenius and Bellomo, 1986; Farber, 1981) . The depression of calcium sequestration in the mitochondria appears to be related to the mechanism of drug toxicity. Mitochondrial calcium sequestration can be reversed in vitro by immediate treatment with N-acetyl-L-cysteine rich in -SH (Aggarwal et al., 1890a,b) . Cell lines shown to be resistant to cisplatin treatment have been demonstrated to possess larger than normal shares of amino acids rich in thiol groups (Howell et al., 1983) . Epithelial cells increase their rate of proliferation with reduced Ca2+ concentrations, whereas raising CaZ+ to physiological levels reduces this hyperproliferation (Lipkin et al., 1989 ). It appears that the toxicities associated with cisplatin may not be the direct result of cisplatin interaction but rather represent the secondary effects of Ca2+ alterations. We have demonstrated intracellular calcium changes in both murine peritoneal macrophages and sarcoma-180 cells after cisplatin or carboplatin treatment (Palma and Aggarwal, 1992) . Similarly, we have demonstrated changes in the membranebound calcium in the p"l tubule cells, using potassium pyroantimonate as the indicator (Aggarwal and Menon, 1981) . Cisplatin is known to induce hypocalcemia in animal and clinical studies, which has been shown to be responsible for various toxicities such as stomach bloating (Roos et al., 1981) and contractions of the uterus inducing embryo resorption (Keller and Aggarwal, 1983) . Ca2+ is required for fusion of the synaptic vesicles to the plasma membrane of the axon endings, causing release of acetylcholine required for contraction of stomach smooth muscle and relaxation of the uterine smooth muscle. Indeed, embryotoxicity has been proposed to be due to an extended contraction of the uterine smooth muscle (Bajt and Aggarwal, 1985) . The numbers of synaptic vesicles in the axon endings of the smooth muscles of the stomach and the uterus increase after cisplatin treatment (Aggarwal and SanAntonio, 198l) , although the amount of acetylcholinesterase seems to be unaffected.
Ca2+ has been demonstrated to be associated with gluconeogenesis (Nagata and Rasmussen, 1970) . We have observed accumulations of glycogen in diverse tissues such as kidney, pituicytes in Table 2 the posterior pituitary, and lymphocytes from animals after cisplatin treatment (Aggarwal and Fadool, 1987) . Again, delayed rigor mortis in cisplatin-treated animals indicates paralysis of muscle contraction due to hypocalcemia (Aggarwal et al., 1980a,b) , while tetany has been demonstrated in some clinical cases after cisplatin treatment (Green et al., 1980; Hayes et al., 1979) .
. Relative nephrotomcity of various platinum coordination complexes as measured by their decreased activity of various membrane associated transport enzymes a f t r I days in the rdidney
Modulation of cisplatin nephrotoxicity by substitution of its ligands suggests that kidney toxicity is not solely related to the platinum atom (Goldstein and Mayor, 1983) . Various metabolites of the cisplatin complex, rather than the platinum atom, mediate the nephrotoxicity. The hydrolysis products of cisplatin react rapidly with ATPase proteins, with inhibition reaching its maximum after only 10 min of pre-incubation. These hydrolysis products are a thousandfold more inhibitory than other metals such as lead, cadmium, and mercury (Nechay and Saunders, 1978) , and all cause similar pathological lesions in the kidney. We have demonstrated that the membrane glycoproteins such as alkaline phosphatase are not inactivated but rather are stripped from the membrane and are discharged into the urine with almost all of their enzymic activity intact (Batzer and Aggarwal, 1986; Aggarwal and Hamouda, 1980) . Morphometric measurements of a random section show that as much as 85% of the enzyme may be removed after 3 days of CDDP action. Similarly, it is hypothesized that Na',K'-ATPase and Ca2',Mg2'-ATPase, which are also an integral part of the plasma membrane, are not inactivated but are stripped just like the AP. A similar stripping effect of cisplatin has been demonstrated on sialic acid in normal splenocytes and transformed lymphocytes (Prasad and Sodhi, 1981) . For these to be inactivated would require very high concentrations (280 pM) not available under chemotherapeutic regimens (Litterst, 1984; Friedman and Melius, 1977) . This stripping of the glycoproteins may be possible through a number of mechanisms that must be explored further. Our studies do demonstrate loss of membrane-associated calcium and -SH groups, while spin-labeled probes have documented fluidity changes in the cell membranes after CDDP (Andrews et al., 1988) . It may not be wrong to conjecture here that these ions or thiol groups are involved in holding various glycoproteins in place (Siddik et al., 1988; Batzer and Aggarwal, 1986) . The activity of various glycoproteins (e.g., AP, 5'-N, Na',K+-ATPase) on the plasma membrane recovers within 30 days after CDDP treatment, contrary to published reports (Wilson, 1973) , and is reversible.
Cisplatin affects all the ATPase activity of the plasma membrane irrespective of the cell-cycle stage (Aggarwal and Niroomand-Rad, 1983) . Lowering the internal concentration of Pi in the mitochondria with various inhibitors leads to the release of accumulated CaZ+ that is related to the permeability of the membrane and inactivation of Ca2+-ATPase (Aggarwal et al., 1980b; Binet and Volfin, 1977) . Increased levels of intracellular Ca2+ are known to shut down Na+,K+-ATPase activity (Guarino et al., 1979) . The functions of ATPases in kidney filtration are well documented (Stekhoven and Bonting, 1981) . Shutting down Na',K+-ATPase inhibits sodium reabsorption, thus leading to renal salt wasting (Hutchinson et al., 1988; Daley-Yates and McBrien, 1982) and causing symptomatic orthostatic hypotension and hyponatremia (Hutchinson et al., 1988; Aggarwal, 1982) . Inhibition of ATP synthesis by various combinations, such as uncoupling of mitochondrial oxidative phosphorylation, inhibition of glycolysis resulting in rapid ATP depletion, and depletion of Na+,K+-ATPase in the cell membrane through limitation of ATP synthesis, results in increased cytosolic Na' and decreased Na+-Ca2+ exchange, forcing increased cytosolic Ca" and activation of Ca2+-calmodulin complexes. ATP deficiency would also deactivate Ca2+-ATPase at the plasma membrane, resulting in increased cytosolic Ca2+ (Trump et al., 1984) . 5'-Nucleotidase has been extensively studied as an ectoenzyme and is often bound to the brush borders of various cells (Dawson et al., 1989; Rodan et al., 1977) . It is also one of the enzymes directly involved in the metabolism of adenosine and indirectly in the synthesis of ATP and cyclic AMP and its breakdown (Vorbrodt and Borun, 1979) . Nucleotides cannot traverse the plasma membrane and must be dephosphorylated with the help of 5"Kleotidase so that the nucleoside product can be internalized (Riordan and Forstner, 1978; Ronquist, 1975) . Inhibition or stripping of the enzyme by cisplatin would lead to indirect inhibition of DNA synthesis through non-availability of various nucleosides, thus interfering with cell metabolism and replication.
Alterations of membrane-associated enzymes are not only implicated in the nephrotoxicity mechanisms of cisplatin and its derivatives but are also involved in various multidrug-resistance mechanisms (Hamada and Tsuruo, 1988) . Alkaline phosphodiesterase activity in all the resistant sublines has been shown to be higher than that in the parental cells (Sugimoto et al., 1981) .
Whatever 1988), the kidney has been proven to be the principal storage depot for platinum. There is an increase in the number of large lysosomes after platinum drug use (Miller and Aggarwal, 1992; Litterst, 1984; Dobyan et al., 1981; Aggarwal et al., 1980b; Choie et al., 1980) and, like Hg, Pt has been shown to accumulate in the lysosomes and peroxisomes in both the kidney and the liver (Levi et al., 1980) . Not only is there an increase in the number of lysosomes but various lysosomal enzymes, such as 0-glucuronidase, alkaline phosphatase, and acid phosphatase, are also increased (Litterst, 1984; Aggarwal et al., 1980a) . The lysosomes have been demonstrated to be very fragile and are probably responsible for cell lysis (Aggarwal et al., 1980a,b) , with liberation of enzymes into the urine in a functional state (Batter and Aggarwal, 1986) . CDDP tends to induce a significant decrease of transport enzyme activity in the cell membranes, with corresponding increases in urinary enzyme levels (Batter and Aggarwal, 1986) . CBDCA, a second-generation analogue of cisplatin, does not produce nearly the same effect on urinary alkaline phosphatase levels, but it does induce a considerable increase in acid phosphatase levels (Batzer and Aggarwal, 1986) . Although CBDCA is less nephrotoxic than cisplatin, it has about the same anti-metastatic effects at 10 times the chemotherapeutic dose.
In conclusion, we propose that the mechanism of action of cisplatin in terms of nephrotoxicity is multifunctional (Figure 22 ), although its primary action is on mitochondrial respiration through its hydrolysis products and those of its analogues. The hydrolysis of CDDP and its analogues can take place only in conditions of low chloride ion concentrations within the cell. Cisplatin and its various analogues probably affect the Ca2+ receptors on the kidney cells to different degrees, causing hypocalcemia which, in turn, induces cytotoxicity in different organ systems via inhibition of the release of various neurotransmitters and by inactivating contractile proteins. Arrest of the mitochondrial respiratory chain causes efflux of Ca2+ which, in turn, causes depolymerization of various contractile proteins, inhibits ATP synthesis, and affects various ATPases (Na',K+-ATPase and Ca2'/Mg'-ATPase). Such an action causes ion imbalance in the cell, leading to stripping of various glycoproteins from the plasma membrane. The cells respond to the foreign substance by sequestering (Pt drugs) into and increasing the number of lysosomes. However, heavy metals are known to induce leakage of the lysosomes, causing the release of hydrolytic enzymes into the cytosol and leading to eventual cell death. Chlorosis can interrupt the process by reverting the aqueated species cz~-[(NH3)2 Pt(H20)2I2' back to the parent compound cZ'-((NH3)2PtCl~] which can be excreted into the urine or sequestered into the lysosomes. Inhibition of VSP release or diuresis can also flush the kidney of various platinum compounds, minimizing their accumulation in kidney cells. 
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